Morgan Stanley 908 Devices Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in 908 Devices Inc. stock. As of the latest transaction made, Morgan Stanley holds 554,245 shares of MASS stock, worth $4.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

554,245

Previous 531,609 4.26%

Holding current value

$4.98 Million

Previous $2.38 Million 65.94%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$3.63 - $7.97 $82,168 - $180,408	22,636 Added 4.26%	554,245 $3.95 Million
Q1 2025 May 15, 2025	BUY	$1.98 - $4.58 $524,781 - $1.21 Million	265,041 Added 99.43%	531,609 $2.38 Million
Q4 2024 Feb 14, 2025	BUY	$1.88 - $3.91 $305,682 - $635,754	162,597 Added 156.39%	266,568 $586,000
Q3 2024 May 14, 2025	BUY	$3.45 - $6.17 $225,340 - $402,999	65,316 Added 168.97%	103,971 $360,000
Q3 2024 Nov 14, 2024	BUY	$3.45 - $6.17 $225,340 - $402,999	65,316 Added 168.97%	103,971 $360,000
Q2 2024 May 14, 2025	SELL	$5.0 - $7.24 $1.14 Million - $1.65 Million	-227,913 Reduced 85.5%	38,655 $199,000
Q2 2024 Oct 17, 2024	BUY	$5.0 - $7.24 $3,220 - $4,662	644 Added 1.69%	38,655 $199,000
Q2 2024 Aug 14, 2024	BUY	$5.0 - $7.24 $3,220 - $4,662	644 Added 1.69%	38,655 $199,000
Q1 2024 Oct 17, 2024	SELL	$6.55 - $9.92 $4,218 - $6,388	-644 Reduced 1.67%	38,011 $286,000
Q1 2024 Aug 16, 2024	SELL	$6.55 - $9.92 $211,656 - $320,554	-32,314 Reduced 45.95%	38,011 $286,000
Q1 2024 May 15, 2024	SELL	$6.55 - $9.92 $211,656 - $320,554	-32,314 Reduced 45.95%	38,011 $286,000
Q4 2023 Aug 16, 2024	BUY	$4.96 - $12.41 $157,083 - $393,024	31,670 Added 81.93%	70,325 $789,000
Q4 2023 Feb 13, 2024	BUY	$4.96 - $12.41 $141,424 - $353,846	28,513 Added 68.19%	70,325 $789,000
Q3 2023 Nov 15, 2023	SELL	$6.0 - $8.2 $226,170 - $309,099	-37,695 Reduced 47.41%	41,812 $278,000
Q2 2023 Aug 14, 2023	SELL	$5.78 - $10.02 $195,537 - $338,976	-33,830 Reduced 29.85%	79,507 $545,000
Q1 2023 May 15, 2023	BUY	$6.61 - $10.66 $205,253 - $331,014	31,052 Added 37.74%	113,337 $974,000
Q4 2022 Feb 14, 2023	BUY	$7.0 - $17.96 $113,330 - $290,772	16,190 Added 24.5%	82,285 $627,000
Q3 2022 Nov 14, 2022	SELL	$15.18 - $24.99 $737,869 - $1.21 Million	-48,608 Reduced 42.38%	66,095 $1.09 Million
Q2 2022 Oct 27, 2022	BUY	$13.3 - $20.74 $1.24 Million - $1.94 Million	93,390 Added 438.18%	114,703 $2.36 Million
Q2 2022 Aug 15, 2022	BUY	$13.3 - $20.74 $1.24 Million - $1.94 Million	93,390 Added 438.18%	114,703 $2.36 Million
Q1 2022 Oct 27, 2022	SELL	$13.18 - $26.28 $1.23 Million - $2.45 Million	-93,390 Reduced 81.42%	21,313 $404,000
Q1 2022 May 13, 2022	SELL	$13.18 - $26.28 $71,606 - $142,779	-5,433 Reduced 20.31%	21,313 $404,000
Q4 2021 Feb 14, 2022	SELL	$23.17 - $38.77 $486,129 - $813,433	-20,981 Reduced 43.96%	26,746 $692,000
Q3 2021 Nov 15, 2021	BUY	$29.99 - $39.13 $1.43 Million - $1.87 Million	47,727 New	47,727 $1.55 Million

Others Institutions Holding MASS

# of Institutions

106

Shares Held

24.4M

Call Options Held

39K

Put Options Held

11.9K

View Full List

About 908 Devices Inc.

Ticker MASS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,590,200
Market Cap $284M
Description
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...

More about MASS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account